Ginkgo Bioworks Holdings Return on Investment 2020-2022 | DNA
Current and historical return on investment (ROI) values for Ginkgo Bioworks Holdings (DNA) over the last 10 years.
| Ginkgo Bioworks Holdings ROI - Return on Investment Historical Data |
| Date |
TTM Net Income |
LT Investments & Debt |
Return on Investment |
| 2022-12-31 |
$-2.21B |
|
-185.71% |
| 2022-09-30 |
$-3.66B |
$1.50B |
-230.55% |
| 2022-06-30 |
$-3.03B |
$1.62B |
-187.17% |
| 2022-03-31 |
$-2.45B |
$1.64B |
-201.19% |
| 2021-12-31 |
$-1.83B |
$1.59B |
-226.92% |
| 2021-06-30 |
$-0.15B |
|
inf% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$2.549B |
$0.478B |
|
Ginkgo Bioworks platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo Bioworks, formerly known as Soaring Eagle Acquisition Corp., is based in NEW YORK.
|
